Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Moxifloxacin AF Ophthalmic Solution for Treatment of Bacterial Conjunctivitis.

Next Previous
Trial Profile

Moxifloxacin AF Ophthalmic Solution for Treatment of Bacterial Conjunctivitis.

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 04 Jan 2018

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Moxifloxacin (Primary)
  • Indications Bacterial conjunctivitis
  • Focus Therapeutic Use
  • Sponsors Alcon

Most Recent Events

  • 14 Jun 2011 Results published in the Advances in Therapy.
  • 19 May 2010 Actual end date (Mar 2010) added as reported by ClinicalTrials.gov.
  • 19 May 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top